| Microbial larvicide application by a large-scale, community-based program reduces malaria infection prevalence in urban Dar es Salaam, Tanzania Y Geissbühler, K Kannady, PP Chaki, B Emidi, NJ Govella, V Mayagaya, ... PloS one 4 (3), e5107, 2009 | 251 | 2009 |
| A tool box for operational mosquito larval control: preliminary results and early lessons from the Urban Malaria Control Programme in Dar es Salaam, Tanzania U Fillinger, K Kannady, G William, MJ Vanek, S Dongus, D Nyika, ... Malaria journal 7, 1-25, 2008 | 229 | 2008 |
| Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania Y Geissbühler, P Chaki, B Emidi, NJ Govella, R Shirima, V Mayagaya, ... Malaria journal 6, 1-17, 2007 | 191 | 2007 |
| Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: an observational study using the US Department of Defense … G Capkun, F Dahlke, R Lahoz, B Nordstrom, HH Tilson, G Cutter, ... Multiple sclerosis and related disorders 4 (6), 546-554, 2015 | 123 | 2015 |
| Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry K Hellwig, Y Geissbuehler, M Sabidó, C Popescu, A Adamo, J Klinger, ... Journal of neurology 267, 1715-1723, 2020 | 81 | 2020 |
| A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project S Lopez-Leon, Y Geissbühler, M Sabidó, M Turkson, C Wahlich, JK Morris Journal of neurology 267 (9), 2721-2731, 2020 | 49 | 2020 |
| Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure Y Geissbühler, J Vile, G Koren, M Guennec, H Butzkueven, H Tilson, ... Therapeutic Advances in Neurological Disorders 11, 1756286418804760, 2018 | 39 | 2018 |
| Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden KM Hakkarainen, R Juuti, S Burkill, Y Geissbühler, M Sabidó, C Popescu, ... Therapeutic advances in neurological disorders 13, 1756286420951072, 2020 | 27 | 2020 |
| The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis S Burkill, P Vattulainen, Y Geissbuehler, M Sabido Espin, C Popescu, ... PLoS One 14 (12), e0227120, 2019 | 26 | 2019 |
| New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis D Rothenbacher, G Capkun, H Uenal, H Tumani, Y Geissbühler, H Tilson Current Medical Research and Opinion 31 (5), 953-965, 2015 | 16 | 2015 |
| Comorbid disease burden among MS patients 1968–2012: A Swedish register–based cohort study KA Smith, S Burkill, A Hiyoshi, T Olsson, S Bahmanyar, D Wormser, ... Multiple Sclerosis Journal 27 (2), 268-280, 2021 | 15 | 2021 |
| Core data elements for pregnancy pharmacovigilance studies using primary source data collection methods: Recommendations from the IMI ConcePTION project JL Richardson, A Moore, RL Bromley, M Stellfeld, Y Geissbühler, ... Drug Safety 46 (5), 479-491, 2023 | 14 | 2023 |
| Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: stratification by maternal and newborn characteristics … M Korjagina, KM Hakkarainen, S Burkill, Y Geissbühler, M Sabidó, ... Multiple sclerosis and related disorders 48, 102694, 2021 | 14 | 2021 |
| Pregnancy outcomes from fingolimod clinical trials and post-marketing experience and the need for a multinational Gilenya (TM)(fingolimod) Pregnancy Exposure Registry in … Y Geissbühler, H Butzkueven, S Hernandez-Diaz, K Hellwig, G Koren, ... Multiple Sclerosis Journal 18, 44-44, 2012 | 14 | 2012 |
| Pregnancy and infant outcomes with interferon beta: data from the European Interferon Beta Pregnancy Registry and population based registries in Finland and Sweden K Hellwig, Y Geissbuehler, M Sabidó, C Popescu, A Adamo, J Klinger, ... Multiple sclerosis and related disorders 26, 240, 2018 | 12 | 2018 |
| The economic burden of Chagas disease: A systematic review MV Andrade, KVMS Noronha, A de Souza, AS Motta-Santos, PEF Braga, ... PLOS Neglected Tropical Diseases 17 (11), e0011757, 2023 | 11 | 2023 |
| Cumulative data on pregnancy outcomes after exposure to fingolimod and in comparison with the general population Y Geissbuhler, J Vile, G Koren, H Wang, H Butzkueven, H Tilson, ... MULTIPLE SCLEROSIS JOURNAL 22, 348-348, 2016 | 10 | 2016 |
| The burden of Chagas disease in the contemporary world: the RAISE study ALP Ribeiro, Í Machado, E Cousin, P Perel, C Demacq, Y Geissbühler, ... Global Heart 19 (1), 2, 2024 | 9 | 2024 |
| Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry C Patry, LD Sauer, A Sander, K Krupka, A Fichtner, J Brezinski, ... Pediatric Nephrology 38 (5), 1621-1632, 2023 | 7 | 2023 |
| Predicting clinical remission of chronic urticaria using random survival forests: machine learning applied to real-world data I Pivneva, MM Balp, Y Geissbühler, T Severin, S Smeets, J Signorovitch, ... Dermatology and Therapy 12 (12), 2747-2763, 2022 | 7 | 2022 |
